Developer docs
API playgroundTry for free, no card

Search company profiles

AvevoRx

Full company profile

uuid000575w

Namestring
AvevoRx
Legal namestring
AvevoRx
Websiteurl
avevorx.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

AvevoRx is a privately held specialty infusion pharmacy headquartered in Greensboro, North Carolina, founded in 2021. The company dispenses high-cost specialty pharmaceuticals—primarily Alpha-1 antitrypsin augmentation therapies, IVIG/SCIG immunoglobulin products, and total parenteral nutrition (TPN)—and pairs dispensing with in-home clinical nursing services for patients with chronic and rare conditions. The operating model combines licensed pharmacy infrastructure (six locations across Greensboro NC, Austin TX, Jasper GA, Muncie IN, Ceres CA, and Fort Lauderdale FL), a 425+ strong clinical workforce (200+ field clinicians and 225+ company-employed nurses), and pharmacy licensure in 45 states plus Washington, D.C., covering approximately 97% of the U.S. population.

AvevoRx holds limited distribution designation for all four FDA-approved Alpha-1 antitrypsin augmentation therapies and serves as a launch partner for Kedrion's QIVIGY brand of IVIG. The company maintains managed care contracts covering 18+ million lives through BCBS affiliates, Cigna, HAP, and PBMs including Capital Rx and Navitus, and operates under URAC and ACHC specialty pharmacy accreditations. Growth has been substantially inorganic, with four acquisitions completed between 2021 and 2026 (Mid Valley Health, Access to Care, Infupharma, Sunrise Rx), producing 2,000%+ cumulative three-year revenue growth and a ~$90 million run rate.

The revenue model spans four streams: specialty drug dispensing (transactional per-script economics), home infusion nursing (managed services), TPN services (managed services), and managed care contracting (long-term payor agreements). AvevoRx is led by five co-founders—Lauren Pumphrey, Eric Hill, Phil Rielly, Robin Johnson, and Courtney Remley—with additional senior leadership across managed care, industry relations, nutrition, nursing, and pharmacy operations.

Short descriptiontext

AvevoRx is a specialty infusion pharmacy dispensing Alpha-1 antitrypsin, IVIG/SCIG, and TPN therapies, paired with in-home nursing services for chronic and rare disease patients across 45 states plus Washington, D.C.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersGreensboro, United States
HQ citystring
Greensboro
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty infusion pharmacy, home infusion services, immune globulin therapy, Alpha-1 antitrypsin deficiency, total parenteral nutrition
Industry2 codes
PRIMARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHSABACAH
Medication Reconciliation & Skilled Medication Administration (Clinical)
Home & Personal Services/Elder Care & In-Home Care Services/Skilled Nursing & Clinical Home Health
NAICS code2 codes
  • Home Health Care Services621610
  • Ambulatory Health Care Services621
SIC code2 codes
  • Services-Home Health Care Services8082
  • Services-Health Services8000
Product category
Specialty Infusion Pharmacy
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Specialty Drug Dispensing
TypeTransaction Fee
Description

Revenue generated from dispensing specialty infusion medications including IVIG, Alpha-1 therapies, TNF blockers, and biologics through licensed pharmacy locations

avevorx.com
2Home Nursing Visits
TypeManaged Services
Description

Revenue from in-home infusion nursing services, with over 21,000 nursing visits projected in 2025 representing 70% year-over-year growth

avevorx.com
3Total Parenteral Nutrition (TPN)
TypeManaged Services
Description

Customized parenteral nutrition solutions for patients with complex gastrointestinal disorders who cannot absorb nutrients through digestive system

avevorx.com
4Managed Care Contracts
TypeSubscription Recurring
Description

Revenue from contracted services with health insurers, managed care organizations, PBMs, and payors covering expanded patient populations

avevorx.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Insurance-dependent specialty infusion services
ModelOtherBilling cadencePay-as-you-go
Notes

Services coordinated through payors, providers, and PBMs. Patient costs dependent on individual insurance coverage, benefits verification, and prior authorization processes. Contact via 877-283-8679 for service inquiries.

avevorx.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

AvevoRx is a national independent specialty infusion pharmacy that provides home and ambulatory infusion care for patients with complex chronic conditions. Its core services include immune globulin (IG) therapy, TNF blockers, Alpha-1 proteinase inhibitor augmentation therapy, bleeding disorder management, and total parenteral nutrition (TPN), supported by a 200+ nurse field workforce and six licensed pharmacy locations with sterile compounding clean-room facilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 96% year-over-year revenue growth in FY2024
+4 more records
Product overview1 text field

AvevoRx is a national independent specialty infusion pharmacy provider offering a unified platform of home infusion and specialty pharmacy services for patients with complex, chronic conditions. The core product is specialty infusion pharmacy services, which includes immune globulin (IG) therapy, TNF blockers (infliximab, golimumab), Alpha-1 proteinase inhibitors, bleeding disorder management, and monoclonal antibody treatments. The company operates AvevoRx Nutrition as a dedicated sub-brand for total parenteral nutrition (TPN) services, featuring intestinal rehabilitation programs and nutrition education. Additional services include the Alpha-1 Advocacy Program for patient support and education, in-home nursing/infusion services with over 200 field clinicians, and patient advocate services providing single points of contact throughout the care journey. Treatments are delivered through specialized pharmacy locations, field nurses, and dedicated support staff throughout the United States.

Product and service10 records
1Specialty Infusion Pharmacy Services
CategorySpecialty Infusion Pharmacy
Description

National independent specialty infusion pharmacy providing home infusion care for patients with immune deficiencies, autoimmune disorders, Alpha-1 antitrypsin deficiency, inflammatory conditions, bleeding disorders, and other complex chronic conditions; delivered through licensed pharmacy locations and a 225+ nurse field workforce.

2Immune Globulin (IG) Therapy
CategorySpecialty Infusion Therapy
Description

Purified concentration of human antibodies administered via infusion to treat primary and secondary immune deficiencies and autoimmune disorders; delivered at home or in ambulatory settings.

3TNF Blocker Therapy (Infliximab, Golimumab)
CategorySpecialty Infusion Therapy
Description

Monoclonal antibody therapy targeting tumor necrosis factor to suppress inflammation; FDA-approved for ankylosing spondylitis, Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis.

4Alpha-1 Proteinase Inhibitor Therapy
CategorySpecialty Infusion Therapy
Description

Intravenous augmentation therapy for Alpha-1 Antitrypsin Deficiency (AATD); AvevoRx is the only privately held provider with access to all four FDA-approved Alpha-1 therapies (Glassia, Aralast, Zemaira, and one additional).

5Bleeding Disorder Management
CategorySpecialty Infusion Therapy
Description

Comprehensive care for hemophilia A, hemophilia B, von Willebrand Disease, and additional rare bleeding disorders including Factor VII, Factor XIII deficiencies, and Glanzmann's Thrombasthenia.

6Total Parenteral Nutrition (TPN) Program
CategoryHome Nutrition Therapy
Description

Specially formulated mixture of nutrients administered intravenously for individuals who cannot absorb nutrients through their digestive system; includes custom HPN solutions and one-to-one counseling for patients with severe GI disorders and Short Bowel Syndrome.

7AvevoRx Nutrition
CategoryHome Nutrition Therapy
Description

Dedicated nutrition services brand offering home parenteral nutrition support, intestinal rehabilitation programs, and nutrition education through a team of Registered Dietitians, Registered Nurses, and Board-Certified Pharmacists specializing in home TPN.

8Alpha-1 Advocacy Program
CategoryPatient Advocacy Services
Description

High-touch nationwide advocacy, education, and patient engagement platform for Alpha-1 Antitrypsin Deficiency patients; includes family and genetic testing coordination, financial assistance navigation, and dedicated patient advocates.

9Home Nursing and Infusion Services
CategoryHome Infusion Nursing
Description

In-home infusion therapy administration by trained nurses with self-infusion training options for patients and caregivers; projected 21,000+ nursing visits in 2025 with over 200 field clinicians across multiple states.

10Patient Advocate Services
CategoryPatient Advocacy Services
Description

Single point of contact patient advocates who help navigate insurance authorizations, treatment options, and therapy management, and coordinate between patients, providers, and payers.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1Sunrise Rx (Acquisition)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-04
Description

Acquisition of Sunrise Rx, a Long Island-based specialty infusion pharmacy, expanding AvevoRx's presence across New York, New Jersey, Connecticut, and New Hampshire. Founded by Rich Collins and Dan Manchise.

avevorx.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-30
Description

AvevoRx selected as network specialty pharmacy to support U.S. launch of QIVIGY, Kedrion's newly approved 10% IVIG therapy. AvevoRx positioned among select group of specialty pharmacies participating in the nationwide launch, integrating QIVIGY into its growing portfolio of specialty infusion therapies.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-08-04
Description

Managed care partnerships with regional BCBS plans in Illinois, Pennsylvania, Western and Northeastern New York, New Jersey, and North Carolina, extending coverage to 18 million additional covered lives.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-08-04
Description

Managed care partnership with Cigna Healthcare of California for specialty infusion services.

5HAP Michigan
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-08-04
Description

Managed care partnership with HAP in Michigan for specialty infusion services.

avevorx.com
Strategic tierStrategicTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-08-04
Description

Partnerships with innovative small-to-medium-sized PBMs disrupting the industry status quo, enabling AvevoRx to introduce its high-touch model to employers and plan sponsors seeking flexible care solutions.

7Global Healthcare Company (Alpha-1 Drug Manufacturer)
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-07-17
Description

Limited distribution agreement for an Alpha-1 proteinase inhibitor (human) completing AvevoRx's suite of treatment offerings for all four FDA-approved Alpha-1 therapies. Agreement grants distribution rights for drugs treating Alpha-1 antitrypsin deficiency (AATD).

avevorx.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-30
Description

Corporate sponsorship partnership with the nonprofit Oley Foundation to support thousands of individuals requiring specialized home parenteral nutrition services. $25,000 contribution as part of national effort to provide home nutrition support services for complex GI conditions.

Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialty infusion pharmacy focused on immune globulin and biologic therapies for primary immune deficiency, autoimmune, and inflammatory conditions. Direct competitor in IVIG/SCIG and immune therapy home infusion with similar patient advocacy focus.

TypeDirect peer
Description

Specialty pharmacy focused on complex conditions including immune deficiencies, autoimmune disorders, and rare diseases. Now a subsidiary of Elevance Health but historically operated as a direct competitor in IVIG, Alpha-1, and biologic infusion therapy distribution.

TypeDirect peer
Description

Largest independent provider of home and alternate-site infusion services in the US, publicly traded (Nasdaq: OPCH). Direct competitor across home infusion therapy delivery, including specialty biologics, with national scale and similar payer contract model.

TypeBroad incumbent
Description

Public diversified home and community-based health services platform (Nasdaq: BTSG) with pharmacy, infusion, and home health segments. Overlaps with AvevoRx's specialty infusion and home nursing model but operates across broader service lines.

TypeDirect peer
Description

Private specialty infusion pharmacy and home infusion services provider focused on IVIG, Alpha-1, immunoglobulin, and biologic therapies. Directly comparable in therapy mix, home nursing model, and specialty pharmacy positioning.

TypeDirect peer
Description

National specialty home infusion provider offering IVIG, biologics, TPN, and home infusion nursing services. Comparable in therapy breadth, geographic coverage, and high-touch patient care model serving chronic complex conditions.

TypeBroad incumbent
Description

National home infusion and specialty pharmacy division of CVS Health. Offers overlapping IVIG, TPN, and biologic infusion capabilities but operates as part of CVS's broader retail, PBM (Caremark), and healthcare portfolio rather than as an independent specialty.

TypeBroad incumbent
Description

Specialty pharmacy division of Walgreens Boots Alliance offering infusion, injectable, and complex therapy management. Competes broadly in specialty drug distribution but lacks AvevoRx's focus on independent, conflict-free home infusion positioning.

TypeDirect peer
Description

Specialty infusion pharmacy focused on IVIG, Alpha-1, and biologic therapies with home and infusion suite administration. Comparable therapy mix, Alpha-1 program emphasis, and home nursing model.

10Diplomat Specialty Pharmacy (OptumRx)
TypeBroad incumbent
Description

Specialty pharmacy now operating within OptumRx/Optum (UnitedHealth Group). Historically a leading independent specialty pharmacy competing in rare disease, oncology, and infusion therapies before acquisition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AvevoRx

Specialty Infusion Pharmacyavevorx.com

AvevoRx is a specialty infusion pharmacy dispensing Alpha-1 antitrypsin, IVIG/SCIG, and TPN therapies, paired with in-home nursing services for chronic and rare disease patients across 45 states plus Washington, D.C.

What AvevoRx does

AvevoRx is a privately held specialty infusion pharmacy headquartered in Greensboro, North Carolina, founded in 2021. The company dispenses high-cost specialty pharmaceuticals—primarily Alpha-1 antitrypsin augmentation therapies, IVIG/SCIG immunoglobulin products, and total parenteral nutrition (TPN)—and pairs dispensing with in-home clinical nursing services for patients with chronic and rare conditions. The operating model combines licensed pharmacy infrastructure (six locations across Greensboro NC, Austin TX, Jasper GA, Muncie IN, Ceres CA, and Fort Lauderdale FL), a 425+ strong clinical workforce (200+ field clinicians and 225+ company-employed nurses), and pharmacy licensure in 45 states plus Washington, D.C., covering approximately 97% of the U.S. population.

AvevoRx holds limited distribution designation for all four FDA-approved Alpha-1 antitrypsin augmentation therapies and serves as a launch partner for Kedrion's QIVIGY brand of IVIG. The company maintains managed care contracts covering 18+ million lives through BCBS affiliates, Cigna, HAP, and PBMs including Capital Rx and Navitus, and operates under URAC and ACHC specialty pharmacy accreditations. Growth has been substantially inorganic, with four acquisitions completed between 2021 and 2026 (Mid Valley Health, Access to Care, Infupharma, Sunrise Rx), producing 2,000%+ cumulative three-year revenue growth and a ~$90 million run rate.

The revenue model spans four streams: specialty drug dispensing (transactional per-script economics), home infusion nursing (managed services), TPN services (managed services), and managed care contracting (long-term payor agreements). AvevoRx is led by five co-founders—Lauren Pumphrey, Eric Hill, Phil Rielly, Robin Johnson, and Courtney Remley—with additional senior leadership across managed care, industry relations, nutrition, nursing, and pharmacy operations.

AvevoRx firmographics

Firmographics
Name
AvevoRx
Legal name
AvevoRx
Website
https://avevorx.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
101–250 employees
Short description
AvevoRx is a specialty infusion pharmacy dispensing Alpha-1 antitrypsin, IVIG/SCIG, and TPN therapies, paired with in-home nursing services for chronic and rare disease patients across 45 states plus Washington, D.C.
Ownership category
akta.pro rank

AvevoRx industry classification

Industry
Product category
Specialty Infusion Pharmacy
NAICS
Home Health Care Services (621610), Ambulatory Health Care Services (621)
SIC
Services-Home Health Care Services (8082), Services-Health Services (8000)
akta.pro industry
PRIMARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHSABACAH
Medication Reconciliation & Skilled Medication Administration (Clinical)
Home & Personal Services/Elder Care & In-Home Care Services/Skilled Nursing & Clinical Home Health

Keywords

  • Specialty infusion pharmacy
  • Home infusion services
  • Immune globulin therapy
  • Alpha-1 antitrypsin deficiency
  • Total parenteral nutrition

Where AvevoRx is headquartered

Location

Headquarters

HQ city
Greensboro
HQ country
United States
HQ region
North America

Offices6 records

Markets served

AvevoRx business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

  1. Specialty Drug Dispensing: Revenue generated from dispensing specialty infusion medications including IVIG, Alpha-1 therapies, TNF blockers, and biologics through licensed pharmacy locations
  2. Home Nursing Visits: Revenue from in-home infusion nursing services, with over 21,000 nursing visits projected in 2025 representing 70% year-over-year growth
  3. Total Parenteral Nutrition (TPN): Customized parenteral nutrition solutions for patients with complex gastrointestinal disorders who cannot absorb nutrients through digestive system
  4. Managed Care Contracts: Revenue from contracted services with health insurers, managed care organizations, PBMs, and payors covering expanded patient populations

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goInsurance-dependent specialty infusion services

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

AvevoRx product offering

Product offering

Core offering

AvevoRx is a national independent specialty infusion pharmacy that provides home and ambulatory infusion care for patients with complex chronic conditions. Its core services include immune globulin (IG) therapy, TNF blockers, Alpha-1 proteinase inhibitor augmentation therapy, bleeding disorder management, and total parenteral nutrition (TPN), supported by a 200+ nurse field workforce and six licensed pharmacy locations with sterile compounding clean-room facilities.

Product overview

AvevoRx is a national independent specialty infusion pharmacy provider offering a unified platform of home infusion and specialty pharmacy services for patients with complex, chronic conditions. The core product is specialty infusion pharmacy services, which includes immune globulin (IG) therapy, TNF blockers (infliximab, golimumab), Alpha-1 proteinase inhibitors, bleeding disorder management, and monoclonal antibody treatments. The company operates AvevoRx Nutrition as a dedicated sub-brand for total parenteral nutrition (TPN) services, featuring intestinal rehabilitation programs and nutrition education. Additional services include the Alpha-1 Advocacy Program for patient support and education, in-home nursing/infusion services with over 200 field clinicians, and patient advocate services providing single points of contact throughout the care journey. Treatments are delivered through specialized pharmacy locations, field nurses, and dedicated support staff throughout the United States.

Differentiator

Problem solved

Functional benefit

Products and services

  • Specialty Infusion Pharmacy Services National independent specialty infusion pharmacy providing home infusion care for patients with immune deficiencies, autoimmune disorders, Alpha-1 antitrypsin deficiency, inflammatory conditions, bleeding disorders, and other complex chronic conditions; delivered through licensed pharmacy locations and a 225+ nurse field workforce.
  • Immune Globulin (IG) Therapy Purified concentration of human antibodies administered via infusion to treat primary and secondary immune deficiencies and autoimmune disorders; delivered at home or in ambulatory settings.
  • TNF Blocker Therapy (Infliximab, Golimumab) Monoclonal antibody therapy targeting tumor necrosis factor to suppress inflammation; FDA-approved for ankylosing spondylitis, Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis.
  • Alpha-1 Proteinase Inhibitor Therapy Intravenous augmentation therapy for Alpha-1 Antitrypsin Deficiency (AATD); AvevoRx is the only privately held provider with access to all four FDA-approved Alpha-1 therapies (Glassia, Aralast, Zemaira, and one additional).
  • Bleeding Disorder Management Comprehensive care for hemophilia A, hemophilia B, von Willebrand Disease, and additional rare bleeding disorders including Factor VII, Factor XIII deficiencies, and Glanzmann's Thrombasthenia.
  • Total Parenteral Nutrition (TPN) Program Specially formulated mixture of nutrients administered intravenously for individuals who cannot absorb nutrients through their digestive system; includes custom HPN solutions and one-to-one counseling for patients with severe GI disorders and Short Bowel Syndrome.
  • AvevoRx Nutrition Dedicated nutrition services brand offering home parenteral nutrition support, intestinal rehabilitation programs, and nutrition education through a team of Registered Dietitians, Registered Nurses, and Board-Certified Pharmacists specializing in home TPN.
  • Alpha-1 Advocacy Program High-touch nationwide advocacy, education, and patient engagement platform for Alpha-1 Antitrypsin Deficiency patients; includes family and genetic testing coordination, financial assistance navigation, and dedicated patient advocates.
  • Home Nursing and Infusion Services In-home infusion therapy administration by trained nurses with self-infusion training options for patients and caregivers; projected 21,000+ nursing visits in 2025 with over 200 field clinicians across multiple states.
  • Patient Advocate Services Single point of contact patient advocates who help navigate insurance authorizations, treatment options, and therapy management, and coordinate between patients, providers, and payers.

Quantifiable outcome

  • 96% year-over-year revenue growth in FY2024
  • +4 more outcomes

Companies that use AvevoRx

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles6 records

AvevoRx technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

AvevoRx partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and strategic.

  • Sunrise Rx (Acquisition)coreStrategic or Co-development Partner · 4 June 2026Acquisition of Sunrise Rx, a Long Island-based specialty infusion pharmacy, expanding AvevoRx's presence across New York, New Jersey, Connecticut, and New Hampshire. Founded by Rich Collins and Dan Manchise.
  • Kedrion BiopharmacoreStrategic or Co-development Partner · 30 March 2026AvevoRx selected as network specialty pharmacy to support U.S. launch of QIVIGY, Kedrion's newly approved 10% IVIG therapy. AvevoRx positioned among select group of specialty pharmacies participating in the nationwide launch, integrating QIVIGY into its growing portfolio of specialty infusion therapies.
  • Blue Cross Blue Shield AffiliatescoreChannel Partner/ Reseller/ Distributor · 4 August 2025Managed care partnerships with regional BCBS plans in Illinois, Pennsylvania, Western and Northeastern New York, New Jersey, and North Carolina, extending coverage to 18 million additional covered lives.
  • Cigna Healthcare of CaliforniacoreChannel Partner/ Reseller/ Distributor · 4 August 2025Managed care partnership with Cigna Healthcare of California for specialty infusion services.
  • HAP MichigancoreChannel Partner/ Reseller/ Distributor · 4 August 2025Managed care partnership with HAP in Michigan for specialty infusion services.
  • Capital Rx, Navitus, Abarca Health, SavRx, Maxor PlusstrategicChannel Partner/ Reseller/ Distributor · 4 August 2025Partnerships with innovative small-to-medium-sized PBMs disrupting the industry status quo, enabling AvevoRx to introduce its high-touch model to employers and plan sponsors seeking flexible care solutions.
  • Global Healthcare Company (Alpha-1 Drug Manufacturer)coreChannel Partner/ Reseller/ Distributor · 17 July 2025Limited distribution agreement for an Alpha-1 proteinase inhibitor (human) completing AvevoRx's suite of treatment offerings for all four FDA-approved Alpha-1 therapies. Agreement grants distribution rights for drugs treating Alpha-1 antitrypsin deficiency (AATD).
  • The Oley FoundationcoreStrategic or Co-development Partner · 30 April 2025Corporate sponsorship partnership with the nonprofit Oley Foundation to support thousands of individuals requiring specialized home parenteral nutrition services. $25,000 contribution as part of national effort to provide home nutrition support services for complex GI conditions.

Scale indicators14 records

Recent moves12 records

Expansion highlights5 records

AvevoRx competitors and assessment

Company assessment

Direct peers

  • Nufactor: Specialty infusion pharmacy focused on immune globulin and biologic therapies for primary immune deficiency, autoimmune, and inflammatory conditions. Direct competitor in IVIG/SCIG and immune therapy home infusion with similar patient advocacy focus.
  • BioPlus Specialty Pharmacy: Specialty pharmacy focused on complex conditions including immune deficiencies, autoimmune disorders, and rare diseases. Now a subsidiary of Elevance Health but historically operated as a direct competitor in IVIG, Alpha-1, and biologic infusion therapy distribution.
  • Option Care Health: Largest independent provider of home and alternate-site infusion services in the US, publicly traded (Nasdaq: OPCH). Direct competitor across home infusion therapy delivery, including specialty biologics, with national scale and similar payer contract model.
  • Soleo Health: Private specialty infusion pharmacy and home infusion services provider focused on IVIG, Alpha-1, immunoglobulin, and biologic therapies. Directly comparable in therapy mix, home nursing model, and specialty pharmacy positioning.
  • PromptCare: National specialty home infusion provider offering IVIG, biologics, TPN, and home infusion nursing services. Comparable in therapy breadth, geographic coverage, and high-touch patient care model serving chronic complex conditions.
  • CSI Pharmacy: Specialty infusion pharmacy focused on IVIG, Alpha-1, and biologic therapies with home and infusion suite administration. Comparable therapy mix, Alpha-1 program emphasis, and home nursing model.

Broad incumbents

  • BrightSpring Health Services: Public diversified home and community-based health services platform (Nasdaq: BTSG) with pharmacy, infusion, and home health segments. Overlaps with AvevoRx's specialty infusion and home nursing model but operates across broader service lines.
  • Coram CVS Specialty Infusion Services: National home infusion and specialty pharmacy division of CVS Health. Offers overlapping IVIG, TPN, and biologic infusion capabilities but operates as part of CVS's broader retail, PBM (Caremark), and healthcare portfolio rather than as an independent specialty.
  • Walgreens Specialty Pharmacy: Specialty pharmacy division of Walgreens Boots Alliance offering infusion, injectable, and complex therapy management. Competes broadly in specialty drug distribution but lacks AvevoRx's focus on independent, conflict-free home infusion positioning.
  • Diplomat Specialty Pharmacy (OptumRx): Specialty pharmacy now operating within OptumRx/Optum (UnitedHealth Group). Historically a leading independent specialty pharmacy competing in rare disease, oncology, and infusion therapies before acquisition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

AvevoRx social profiles

Digital presence

AvevoRx compliance and trust

Trust signal

Compliance3 records

AvevoRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AvevoRx leadership team

Management profile

Number of profiles

Profiles12 records

AvevoRx subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

AvevoRx funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AvevoRx M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AvevoRx

What does AvevoRx do?

AvevoRx is a national independent specialty infusion pharmacy that provides home and ambulatory infusion care for patients with complex chronic conditions. Its core services include immune globulin (IG) therapy, TNF blockers, Alpha-1 proteinase inhibitor augmentation therapy, bleeding disorder management, and total parenteral nutrition (TPN), supported by a 200+ nurse field workforce and six licensed pharmacy locations with sterile compounding clean-room facilities.

Is AvevoRx a public or private company?

AvevoRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AvevoRx founded?

AvevoRx was founded in 2021. It employs 101 to 250 people.

Where is AvevoRx based?

AvevoRx is headquartered in Greensboro, United States, in the North America region.

How does AvevoRx make money?

Four revenue lines are on record. Specialty Drug Dispensing is the primary driver. The others are home Nursing Visits, total Parenteral Nutrition (TPN) and managed Care Contracts.

Who are AvevoRx's main competitors?

Direct peers on record are Nufactor, BioPlus Specialty Pharmacy, Option Care Health, Soleo Health, PromptCare and CSI Pharmacy. Broad incumbents are BrightSpring Health Services, Coram CVS Specialty Infusion Services, Walgreens Specialty Pharmacy and Diplomat Specialty Pharmacy (OptumRx).

Does AvevoRx have an API?

No public API is recorded for AvevoRx.

What industry is AvevoRx in?

AvevoRx's product category is Specialty Infusion Pharmacy. Its primary akta.pro industry code is HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms, with a secondary code of HSABACAH, Medication Reconciliation & Skilled Medication Administration (Clinical). Its NAICS code is 621610 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrwebAvevoRx Launches Dedicated Alpha-1 Digital Platform to Expand Patient Education, Advocacy and Physician SupportAvevoRx launched a dedicated Alpha-1 digital platform at AvevoRxAlpha.com to connect patients, families, and physicians with education, advocacy, and care resources. The site provides patient education, insurance navigation, and a direct pathway to a dedicated advocate, expanding the company's Alpha-1 program.PrwebAvevoRx Earns Third Consecutive Triad Fast 50 Recognition Amid Continued National ExpansionAvevoRx was ranked No. 2 overall in the 2026 Triad Business Journal Fast 50, its third consecutive appearance. The Greensboro-based specialty infusion pharmacy also ranked No. 401 on the Inc. 5000 and No. 48 nationally in healthcare. The company serves about 97% of the U.S. population.American City Business JournalsFast 50 revealed: Canter Power, AvevoRx top 2026 rankings of Triad's fastest-growing private companiesCanter Power Systems ranked No. 1 on Triad Business Journal's Fast 50 for 2026, with AvevoRx at No. 2. Canter, the nation's largest residential backup generator installer, is one of 11 first-time honorees. The list includes repeat companies like Tencarva and Sunrise Technologies.American City Business JournalsAvevoRX, K12 Computers lead 18 Triad businesses on 2026 Inc 5000AvevoRX and K12 Computers led the 18 Triad businesses selected for the 2026 Inc. 5000 list of fastest-growing private companies. AvevoRX, based in Greensboro, achieved the highest local ranking, while firms from Winston-Salem, Greensboro, and High Point also secured spots on the list.PrwebAvevoRx Ranked No. 401 on 2026 Inc. 5000, Earns Third Consecutive Recognition Among America's Fastest-Growing Private CompaniesAvevoRx was named to the 2026 Inc. 5000, ranking No. 401 overall and earning its third consecutive recognition. The company serves about 97% of the U.S. population and expanded its pharmacy network and partnerships.PrwebAvevoRx Launches National Nutrition Education and Patient Engagement Initiative, Expands Access for Patients with Complex Nutrition NeedsAvevoRx announced an expanded national nutrition education and patient engagement initiative to improve access to specialized care for patients with complex GI disorders on home parenteral nutrition. The program includes a 12-week at-home intestinal rehabilitation for Short Bowel Syndrome and digital resources, aiming to reduce geographic barriers.PrwebAvevoRx Closes on Acquisition of Sunrise Rx, Expanding Specialty Infusion Pharmacy Presence Across the NortheastAvevoRx closed on the acquisition of Sunrise Rx, a Long Island-based specialty infusion pharmacy, expanding its presence across New York, New Jersey, Connecticut, and New Hampshire. The deal strengthens AvevoRx's operational footprint in the Northeast and supports its national growth strategy. The company now serves approximately 97% of the U.S. population.AvevorxAvevoRx Closes on Acquisition of Sunrise Rx, Expanding Specialty Infusion Pharmacy Presence Across the NortheastAvevoRx closed on the acquisition of Sunrise Rx, a Long Island-based specialty infusion pharmacy, expanding its presence across New York, New Jersey, Connecticut, and New Hampshire. The deal strengthens AvevoRx's operational footprint in the Northeast and supports its national growth strategy, with the company now serving approximately 97% of the U.S. population.LevinassociatesAvevoRx Acquires Sunrise Rx to Expand Specialty Infusion Pharmacy Presence Across the NortheastAvevoRx closed on the acquisition of Sunrise Rx, a specialty infusion pharmacy based in Long Island, New York. Financial terms were not disclosed, and Sunrise Rx co-founder Rich Collins will continue leading New York operations. The deal marks the sixth infusion services acquisition of the year.PrwebAvevoRx Expands Specialty Infusion Pharmacy Network With New Clean-Room Facility in Austin, TexasAvevoRx, a national specialty infusion pharmacy provider, has taken over operations of a pharmacy with a fully equipped clean-room facility in Austin, Texas, expanding its infrastructure in one of the country's fastest-growing healthcare markets. The Austin pharmacy strengthens the company's ability to dispense and manage complex infusion medications across Texas and the broader Southwest region. The expansion follows a recent similar integration of a clean-room pharmacy facility in the Metro Atlanta area as part of AvevoRx's strategy to scale its national specialty infusion platform.